Abstract:Background: Primary central nervous system lymphoma(PCNSL) is an aggressive, rare form of Non-Hodgkin lymphoma, characterized by the absence of systemic disease. There are limited data and no strictly defined guidelines for management of PCNSL. Objective: The aim of this study was to report a 10 year experience of PCNSL treatment, to evaluate treatment outcomes and asses Progression Free and Overall Survival of these patients. Methods: Study was conducted on the Haematology Clinic, Clinical center University of Sarajevo, BH, in the period from January 2012.-December 2022. Total sample of 24 patients were enrolled. All have undergone diagnostic surgery. Patients were treated with regimens based on High dose Methotrexate, with/without whole brain radiotherapy as consolidation. Treatment response was captured by imaging techniques. Patients who have relapsed were evaluated with imaging techniques and treated according to Methotrexate-based treatment protocols. Results: We have captured equal gender distribution. The median age of patients was 59.5 years (range 20-79). Pathohistological analysis confirmed DLBCL diagnosis in 22 patients, T cell lymphoma and anaplastic large cell lymphoma, each in 1 patient. Chemotherapy, chemotherapy combined with WBRT and radiotherapy were given to 5, 18 and 1 patients, respectively. The overall complete response rate (CR) was 87,15%. Those receiving combined modality-treatment had higher CR than those receiving chemotherapy (94,4% versus 60%). Out of 24 patients, 11 of them relapsed. The median time to relapse was 29 months (from 1 to 105). After second line of the treatment, CR was 54,5%, while 45,45% of patients died during the treatment. 4 patients relapsed for the second time with median time to relapse of 9 months (from 2 to 77). 2 year OS rate was 67%, and the median OS rate was 45,9 months. 2 year PFS rate was 31%. Conclusion: The OS and PFS rates indicate the usage of new drugs and consolidation with autologous stem cell transplantation in patients with PCNSL in order to achieve better treatment outcomes.

Study on primary central nervous system lymphoma in pediatric patients

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

Primary central nervous system lymphoma mimicking recurrent depressive disorder: A case report.

Pediatric primary central nervous system lymphoma

Primary central nervous system lymphoma: a series report and literature review

Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases

Primary Central Nervous System Lymphoma, Treatment Outcomes - 10 Year Experience. Single Center Study

Advances in relevant prognostic factors of primary central nervous system lymphoma

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside

A Retrospective Study of 40 Cases of Pathologically Established Primary Central Nervous System Lymphoma

Advances in the Diagnosis of Primary Central Nervous System Lymphoma

[Primary CNS lymphoma--an update]

Primary Central Nervous System Lymphoma: From Clinical Presentation to Diagnosis

Clinical features analysis on primary central nervous system lymphoma

Advances in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma

The Clinical Features and Survival Analysis of Primary Central Nervous System Lymphoma

Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma

Successful Treatment of Primary Central Nervous System Lymphoma without Irradiation in Children: Single Center Experience

Genomic Landscape and Molecular Subtypes of Primary Central Nervous System Lymphoma

Advances and Challenges in the Treatment of Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma: A Report of 7 Cases